TNFRSF17 and Miyoshi myopathy: Recently, the use of immunotherapy, such as chimeric antigen receptor (CAR) T-cell therapy against B-cell maturation antigen (BCMA) and bispecific antibodies in patients with MM has shown encouraging results [28,29,30,31,32].